Basic Search
|
Summaries
|
Advanced SearchViolation Tracker Individual Record
Company: Endo Health Solutions
Current Parent Company:
Endo International
Parent at the Time of the Penalty Announcement:
subscribe to see this data field
Penalty: $39,000,000
Year: 2015
Date: December 16, 2015
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Violation Description: Qualitest Pharmaceuticals, Inc., a manufacturer of generic pharmaceutical products, and its parent company, Endo Health Solutions, agreed to pay $39 million as part of the settlement of multistate litigation alleging unlawful labeling practices; specifically, selling multivitamin tablets said to contain the American Dental Association (ADA) amount of fluoride when they actually contained less than half that amount. Also involved in the settlement was the federal government, which issued its own announcement; see the Violation Tracker entry at
(click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: Ireland
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data:
(click here)
Source Notes: If an online information source is not working, check the Violation Tracker
Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the
Update Log.
